Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Kedudukan dalam Saham #33687
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Harga Saham
$4.70
Disegerakkan terakhir: 2026-08-14
Modal Pasaran
$7.09M
Perubahan (1 hari)
-0.21%
Perubahan (1 tahun)
-70.63%
Negara
US
Perdagangan Apimeds Pharmaceuticals US, Inc (APUS)

Kategori

Sejarah harga saham bagi Apimeds Pharmaceuticals US, Inc (APUS)
Harga penutupan tertinggi: $4.53 pada 2026-08-01

Harga penutupan terendah: $18.03 pada 2025-05-01
Sejarah harga saham Apimeds Pharmaceuticals US, Inc dari 2025 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -15.19%
2025 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$505.24 28.63%
US
$846.09 29.41%
NL
$732.21 6.55%
CH
$1.07K -6.40%
KR
$254.90 13.12%
BE